西班牙拉里奥哈的药房:流行病学及其与社会决定因素的关系:一项描述性研究
Gonzalo Aparicio-Rodríguez1,2, Raúl Juárez-Vela2,3, Amaya Burgos-Esteban2,3,4
1Interuniversity Doctoral Program in Global Health by the University of Zaragoza, the University of La Rioja, the Public University of Navarre, and the University of Lleida, Logroño, La Rioja, Spain.
Frontiers in pharmacology
|November 19, 2025
概括
西班牙拉里奥哈的药物使用显示出大量的质子抑制剂 (PPI) 和抗炎药物,反映了欧盟的趋势. 社会经济因素显著影响药物获取和模式.
科学领域:
- 药物经济学 药物经济学
- 公共卫生 公共卫生
- 老年病的医生 老年病的医生
背景情况:
- 西班牙的预期寿命在欧盟中最高 (2022年为83.2岁),人口老龄化和慢性疾病的增加.
- 增加的药物使用是显而易见的,西班牙国家卫生系统在2022年分发超过11亿包.
- 了解药物发行模式对于公共卫生战略至关重要.
研究的目的:
- 为了评估西班牙拉里奥哈的药物发行.
- 分析药物使用与健康决定因素之间的关系,包括社会经济地位,年龄,性别和地理居住地.
主要方法:
- 一项观察性,回顾性,横截面研究分析了从2016年1月到2023年12月的1,433,531个独特的患者药物记录 (ATC4水平).
- 数据包括年龄,性别,社会经济水平,药物类型和健康区域.
- 统计分析使用了奇平方和克鲁斯卡尔-瓦利斯测试 (p <0.05).
主要成果:
- 质子抑制剂 (PPI) 和酸衍生抗炎药物是最常使用的药物.
- 在2016年至2023年期间,抗抑郁药的发行量增加了41.8% (ATC4子组N06AX).
- 女性的处方率更高 (53.7%),特别是甲状腺激素和抗抑郁药,而男性的心血管药物的处方率更高. 老年人群也显示出高心血管药物使用率. 社会经济地位与特定的药物类别相关.
结论:
- 拉里奥哈的药物发行与国家和欧盟的趋势保持一致,主要是PPE和抗炎药物.
- 性别,年龄,地理区域,社会经济地位和药物使用模式之间存在显著的关联.
- 公共卫生干预措施应解决这些决定因素,以促进合理的药物使用和公平的获取.
更多相关视频
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
885
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
885
Introduction to Epidemiology
1.6K
Epidemiology, known as the cornerstone of public health, involves studying the distribution and determinants of health-related events in defined populations and applying these insights to control health issues. This is essential for understanding how diseases spread, identifying populations at greater risk, and implementing measures to control or prevent outbreaks. Epidemiology addresses not only infectious diseases but also non-communicable conditions like cancer and cardiovascular disease,...
1.6K
Bias in Epidemiological Studies
1.2K
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
1.2K
Dosage Regimens: Partial Pharmacokinetic Parameters
138
It is not uncommon for complete drug pharmacokinetic profiles to remain elusive in pharmacokinetics. This necessitates certain educated assumptions by pharmacokineticists to determine appropriate dosage regimens without comprehensive pharmacokinetic data from animal or human studies. One prevalent assumption is setting the bioavailability factor, denoted as F, to 1 or 100%. This assumption caters to the scenario where a drug doesn't achieve full systemic absorption, resulting in the patient...
138
Study Designs in Epidemiology
860
Epidemiological study designs are fundamental tools for investigating the distribution, determinants, and control of health conditions in populations. They help researchers understand the relationships between exposures and outcomes, and they broadly fall into two categories: "observational" and "experimental" studies.
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
Observational studies are those where the researcher does not intervene but rather observes natural variations. They include cross-sectional, cohort, and...
860
Analysis of Population Pharmacokinetic Data
659
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
659


